Oncolytic vesicular stomatitis virus induces apoptosis in U87 glioblastoma cells by a type II death receptor mechanism and induces cell death and tumor clearance in vivo
about
Oncolytic viruses as therapeutic cancer vaccinesVesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancerUnderstanding and altering cell tropism of vesicular stomatitis virusUse of Lentiviral Particles As a Cell Membrane-Based mFasL Delivery System for In Vivo Treatment of Inflammatory Arthritis.Current status of gene therapy for brain tumors.Induction of apoptosis in pancreatic cancer cells by vesicular stomatitis virus.Inactivated Sendai virus strain Tianjin induces apoptosis in breast cancer MCF-7 cells by promoting caspase activation and Fas/FasL expression.Changes in Susceptibility to Oncolytic Vesicular Stomatitis Virus during Progression of Prostate Cancer.Unlocking the promise of oncolytic virotherapy in glioma: combination with chemotherapy to enhance efficacyInterferon Beta and Interferon Alpha 2a Differentially Protect Head and Neck Cancer Cells from Vesicular Stomatitis Virus-Induced Oncolysis.Histone deacetylase inhibitors potentiate vesicular stomatitis virus oncolysis in prostate cancer cells by modulating NF-κB-dependent autophagyMolecular determinants of susceptibility to oncolytic vesicular stomatitis virus in pancreatic adenocarcinoma.Resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus: role of type I interferon signaling.Vesicular stomatitis virus as an oncolytic agent against pancreatic ductal adenocarcinoma.Carbohydrate-based ice recrystallization inhibitors increase infectivity and thermostability of viral vectors.From Benchtop to Bedside: A Review of Oncolytic Virotherapy.
P2860
Q21245758-5DFEE9EA-2AA7-4221-B5E9-FFC2F2CDFB32Q27021839-1BCFCD17-53ED-46A4-BAF7-1E57349826CBQ27687067-6E8C1AD3-C8FC-46EF-BEFF-B5D4A7C07471Q33586182-811AEC44-3FA9-4F0E-82F2-598BF6F4EFCFQ34318157-9346D601-48FE-49FB-BCB0-7097DE1EEC8EQ34656877-2D74C1E7-F7E8-4C54-85F2-5E690B8E2759Q35068459-AA7BCC9A-03D6-4B7B-90C1-7303D4007DEEQ35641491-752664DC-D57E-4F12-BD3E-FCE17F3B3F87Q35657822-F42C62E1-73A1-4076-8F18-65692659106BQ35861186-B488B9ED-6EDD-4F9D-9898-FAF0035E6359Q37644099-C601A440-93A0-48B9-9370-39CBF577E31CQ37646792-E1041DF4-1C48-42EA-95B1-7AD4690582C2Q39224943-13C10E96-2E0C-4856-B411-FB76196A6859Q39413447-6EC18C46-3517-4378-B14C-0D06F3025326Q41954622-1861D755-BFF9-4982-B33A-DEA7987E01F0Q53272922-209C119F-07DA-4184-8485-E7EDC8242B3E
P2860
Oncolytic vesicular stomatitis virus induces apoptosis in U87 glioblastoma cells by a type II death receptor mechanism and induces cell death and tumor clearance in vivo
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Oncolytic vesicular stomatitis ...... th and tumor clearance in vivo
@ast
Oncolytic vesicular stomatitis ...... th and tumor clearance in vivo
@en
type
label
Oncolytic vesicular stomatitis ...... th and tumor clearance in vivo
@ast
Oncolytic vesicular stomatitis ...... th and tumor clearance in vivo
@en
prefLabel
Oncolytic vesicular stomatitis ...... th and tumor clearance in vivo
@ast
Oncolytic vesicular stomatitis ...... th and tumor clearance in vivo
@en
P2093
P2860
P356
P1433
P1476
Oncolytic vesicular stomatitis ...... th and tumor clearance in vivo
@en
P2093
Douglas S Lyles
Mark C Willingham
Zachary D Cary
P2860
P304
P356
10.1128/JVI.02393-10
P407
P577
2011-03-30T00:00:00Z